The Schisandra market is estimated to grow at a 7.56% CAGR from 2024 to 2031, powered by its adaptogenic, neuroprotective, and anti‑inflammatory benefits in supplements, beverages, and skincare. https://www.datamintelligence.com/research-report/schisandra-market